Hikma Pharmaceuticals Articles
Hikma to retain its global Injectables business
17 April 2013
Hikma to buy Egyptian pharma company for around $20 million
10 January 2013
Solid first-half 2012 results from Jordan's Hikma
16 August 2012
Hikma earnings down despite 25.6% revenue growth
14 March 2012
Hikma adds to stake in Promopharm; gets US appro for argatroban
22 January 2012
Hikma unit to increase focus on contract manufacturing, aimed at alleviating US drug shortages
20 September 2011
Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body
29 April 2011
Merck KGaA sells women’s health business to Teva in $368 million-euro deal; Hikma buys Baxter’s injectable business for $112 million
29 October 2010
Hikma expands its manufacturing capabilities in Algeria taking full control of JV; signs biosimilars deal with CellTrion
13 April 2010
Showing 1-23 of 23 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
